Our Scientific Innovations
Scientific breakthroughs transforming how we treat muscle loss and degeneration.
Our Science Foundation
Our science is driven by a novel mechanism of action that targets key pathways involved in muscle cell stability, regeneration, and repair. By modulating these fundamental biological processes, we aim to restore muscle function and counteract disease progression at its source.
SarcoScreen™
SarcoScreen™ is Sarcomatrix’s proprietary drug discovery and development platform, purpose-built to identify and advance novel therapies for muscle-wasting diseases. Unlike traditional target-based methods, SarcoScreen™ leverages functional assays to assess the real-world biological effects of compounds on muscle cells—prioritizing clinically relevant outcomes such as enhanced regeneration, protection from injury, and restored contractile function.
Platform Advantage
By measuring tangible improvements in muscle performance and pathology, SarcoScreen™ streamlines the discovery of therapeutic candidates with a higher probability of clinical success—particularly for complex, multifactorial diseases such as muscular dystrophies and sarcopenia.
Collaborative Development
Our therapies are developed in collaboration with esteemed researchers and physicians from the University of Nevada School of Medicine and Pharmacology, the University of Illinois, and the University of Minnesota.
